News & Updates

Treatment with ustekinumab can help patients with ulcerative colitis (UC) achieve clinical and endoscopic outcomes of importance after 12 months, results of a real-world study have shown.

Effective antiviral therapy is crucial for achieving sustained viral clearance and improving outcomes in patients with COVID-19, particularly among immunocompromised individuals.

At the recent ESCMID Global 2025 in Vienna, Austria, Ruth Mokgokong, a pharmacologist at Pfizer, UK, presented findings from the EPIC-IC trial, highlighting the benefits of an extended nirmatrelvir-ritonavir regimen in severely immunocompromised patients with symptomatic COVID-19.

A recent study has shown the significant role that BMI plays in the relationship between food insecurity and diabetes.

Several factors contribute to the risk for worse 90-day best-corrected visual acuity (BCVA) in patients with microbial keratitis (MK), and these include initial vision, longer time until presentation, and larger infiltrate size, reports a study.

Early weight loss associated with the use of tirzepatide may significantly improve cardiometabolic health, particularly in adults achieving a normal BMI by week 52, according to a China study.

Cannabis use increases the risk of major adverse cardiovascular events (MACE), as shown in a robust meta-analysis, raising serious questions about the assumptions that cannabis use poses little cardiovascular (CV) risk among users.

The first type 1 diabetes (T1D) genetic risk score (GRS) tailored for the Chinese population, developed by a joint research team from The Chinese University of Hong Kong’s (CUHK), the UK and China, signifies a leap forward in correct diagnosis of diabetes.